Frank Czubayko
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 17
- Glycosylation and Glycoproteins Research 12
- Fibroblast Growth Factor Research 10
- Advanced biosensing and bioanalysis techniques 10
- Cancer Research top 5%
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 8
- Biomaterials top 2%
- Cell Biology top 2%
- Proteoglycans and glycosaminoglycans research 15
-
- Monoclonal and Polyclonal Antibodies Research 14
-
- Virus-based gene therapy research 6
- Co-authors
- Achim AignerAnton WellsteinThomas KisselAnastasia MalekSabrina HöbelMarius GrzelinskiGuy BerchemAnke M. Schulte
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (4 papers)Nature Medicine (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Frank Czubayko
52 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Biology 2.9k
- Cancer Research 611
- Immunology and Allergy 228
- Biomaterials 474
- Cell Biology 474
Countries citing papers authored by Frank Czubayko
This map shows the geographic impact of Frank Czubayko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Czubayko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Czubayko more than expected).
Fields of papers citing papers by Frank Czubayko
This network shows the impact of papers produced by Frank Czubayko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Czubayko. The network helps show where Frank Czubayko may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frank Czubayko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 74 | |
| 2 | 2010 | 91 | |
| 3 | 2010 | 20 | |
| 4 | 2009 | 25 | |
| 5 | 2008 | 56 | |
| 6 | 2005 | 15 | |
| 7 | 2004 | 29 | |
| 8 | 2004 | 34 | |
| 9 | 2003 | 48 | |
| 10 | 2002 | 33 | |
| 11 | 2001 | 59 | |
| 12 | 2001 | 16 | |
| 13 | 2001 | 42 | |
| 14 | 2000 | 30 | |
| 15 | 1997 | 56 | |
| 16 | 1997 | 34 | |
| 17 | 1996 | 24 | |
| 18 | Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. | 1995 | 173 |
| 19 | 1995 | 13 | |
| 20 | 1992 | 15 |
About Frank Czubayko
Frank Czubayko is a scholar working on Immunology and Allergy, Cell Biology and Molecular Biology, having authored 53 papers that have together received 4.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (17 papers), Proteoglycans and glycosaminoglycans research (15 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (12 papers), Fibroblast Growth Factor Research (10 papers), Advanced biosensing and bioanalysis techniques (10 papers), Cell Adhesion Molecules Research (8 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Molecular Biology (2.9k citations), Cancer Research (611 citations) and Immunology and Allergy (228 citations). Frank Czubayko has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Achim Aigner, Anton Wellstein, Thomas Kissel, Anastasia Malek, Sabrina Höbel, Marius Grzelinski, Guy Berchem, Anke M. Schulte, Udo Bakowsky and Anna T. Riegel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.